<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20191203045588N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-12-05</date_registration>
      <primary_sponsor>The university of Mohaghegh Ardabili</primary_sponsor>
      <public_title>Evaluation of The Effect of Resistance Training in obese people</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Interval Resistance Training with different intensity on some selected adipokines in obese men</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-12-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>44</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/59853</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>obesity.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: In this group, obese people do resistance training in a gym for 12 weeks. Their training protocol is as follows: They perform high-intensity circular resistance training, 3 sets of 10repetitions with 80% of a maximum repetition, 3 days a week, each session for 70 minutes. The formulas mentioned in articles and books are used to determine their maximum repetition. In this research, no chemicals, drugs, herbal supplements, etc. are used. Intervention 2: Intervention group 2: In this group, obese people do resistance training in a gym for 12 weeks. Their training protocol is as follows: They do circular resistance training with moderate intensity, 3 sets of 13repetitions with 60% of one maximum repetition, 3 days a week, 70 minutes per session. The formulas mentioned in articles and books are used to determine their maximum repetition. In this research, no chemicals, drugs, herbal supplements, etc. are used. Intervention 3: Intervention group 3: In this group, obese people do resistance training in a gym for 12 weeks. Their training protocol is as follows: They do low-intensity circular resistance training, 3 sets of 20repetitions with 40% of a maximum repetition, 3 days a week, each session for 70 minutes. The formulas mentioned in articles and books are used to determine their maximum repetition. In this research, no chemicals, drugs, herbal supplements, etc. are used. Intervention 4: Control group: This group has their normal and routine life conditions and should avoid any physical activity for 12 weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ensieh Yazdkhasti</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Circle 4, Shahid Abshnasan residential dormitory, Salmas Road</address>
        <city>Urimia</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5754135373</zip>
        <telephone>+98 44 3251 8396</telephone>
        <email>yazdkhasti.ensi@yahoo.com</email>
        <affiliation>The University of Mohaghegh Ardabili</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ensieh Yazdkhasti</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Circle 4 , Shahid Abshnasan residential dormitory, Salmas Road</address>
        <city>Urimia</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5754135373</zip>
        <telephone>+98 44 3251 8396</telephone>
        <email>yazdkhasti.ensi@yahoo.com</email>
        <affiliation>The University of Mohaghegh Ardabili</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>BMI=30
No addiction to drugs and alcohol
No history of regular exercise for at least 6 months
No history of kidney, liver, cardiovascular disease, diabetes
Not having any injuries or physical problems for the subjects</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>30 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E66</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Overweight and obesity</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: In this group, obese people do resistance training in a gym for 12 weeks. Their training protocol is as follows: They perform high-intensity circular resistance training, 3 sets of 10repetitions with 80% of a maximum repetition, 3 days a week, each session for 70 minutes. The formulas mentioned in articles and books are used to determine their maximum repetition. In this research, no chemicals, drugs, herbal supplements, etc. are used.</i_keyword>
      <i_keyword>Intervention group 2: In this group, obese people do resistance training in a gym for 12 weeks. Their training protocol is as follows: They do circular resistance training with moderate intensity, 3 sets of 13repetitions with 60% of one maximum repetition, 3 days a week, 70 minutes per session. The formulas mentioned in articles and books are used to determine their maximum repetition. In this research, no chemicals, drugs, herbal supplements, etc. are used.</i_keyword>
      <i_keyword>Intervention group 3: In this group, obese people do resistance training in a gym for 12 weeks. Their training protocol is as follows: They do low-intensity circular resistance training, 3 sets of 20repetitions with 40% of a maximum repetition, 3 days a week, each session for 70 minutes. The formulas mentioned in articles and books are used to determine their maximum repetition. In this research, no chemicals, drugs, herbal supplements, etc. are used.</i_keyword>
      <i_keyword>Control group: This group has their normal and routine life conditions and should avoid any physical activity for 12 weeks.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Asprosin. Timepoint: 48 hours before and 48 hours after training intervention. Method of measurement: Blood sample, Equipment needed: Date disposable syringe, standard garo or tourniquet, test tube containing anticoagulant (EDTA), sterile cotton, 75% ethanol alcohol , ELISA kit (Made in the USA)  and ELIZA Reader.</prim_outcome>
      <prim_outcome>Neuregulin-4. Timepoint: 48 hours before and 48 hours after training intervention. Method of measurement: Blood sample, Equipment needed: Date disposable syringe, standard garo or tourniquet, test tube containing anticoagulant (EDTA), sterile cotton, 75% ethanol alcohol  , ELISA kit (Made in the USA)  and ELIZA Reader.</prim_outcome>
      <prim_outcome>Leptin. Timepoint: 48 hours before and 48 hours after training intervention. Method of measurement: Blood sample, Equipment needed: Date disposable syringe, standard garo or tourniquet, test tube containing anticoagulant (EDTA), sterile cotton, 75% ethanol alcohol  , ELISA kit (Made in the Czech Republic)  and ELIZA Reader.</prim_outcome>
      <prim_outcome>Adiponectin. Timepoint: 48 hours before and 48 hours after training intervention. Method of measurement: Blood sample, Equipment needed: Date disposable syringe, standard garo or tourniquet, test tube containing anticoagulant (EDTA), sterile cotton, 75% ethanol alcohol,  ELISA kit (Made in the Czech Republic)  and ELIZA Reader.</prim_outcome>
      <prim_outcome>Interleukin 6. Timepoint: 48 hours before and 48 hours after training intervention. Method of measurement: Blood sample, Equipment needed: Date disposable syringe, standard garo or tourniquet, test tube containing anticoagulant (EDTA), sterile cotton, 75% ethanol alcohol , ELISA kit (Made in the Czech Republic)  and ELIZA Reader.</prim_outcome>
      <prim_outcome>Tumor necrosis factor-alpha. Timepoint: 8 hours before and 48 hours after training intervention. Method of measurement: Blood sample, Equipment needed: Date disposable syringe, standard garo or tourniquet, test tube containing anticoagulant (EDTA), sterile cotton, 75% ethanol alcohol  , ELISA kit (Made in Wuhan, China)  and ELIZA Reader.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>The university of Mohaghegh Ardabili</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-11-06</approval_date>
        <contact_name>Ethics Committee of Mohaghegh Ardabili University</contact_name>
        <contact_address>Mohaghegh Ardabil University End of University Street  Ardabil Ardabil Ardabil Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
